98 related articles for article (PubMed ID: 23578691)
1. Using telemetry to automate the detection of emesis in the ferret: new vistas for delayed emesis assessment.
Goineau S; Rompion S; Guillaume P; Barrais L; Castagné V
J Pharmacol Toxicol Methods; 2013; 68(1):160-5. PubMed ID: 23578691
[TBL] [Abstract][Full Text] [Related]
2. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
Goineau S; Guillaume P; Barrais L; Castagné V
Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
[TBL] [Abstract][Full Text] [Related]
3. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
[TBL] [Abstract][Full Text] [Related]
4. Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets.
Percie du Sert N; Chu KM; Wai MK; Rudd JA; Andrews PL
World J Gastroenterol; 2009 Dec; 15(48):6034-43. PubMed ID: 20027675
[TBL] [Abstract][Full Text] [Related]
5. The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret.
Percie du Sert N; Rudd JA; Moss R; Andrews PL
Neurosci Lett; 2009 Nov; 465(1):16-20. PubMed ID: 19733218
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three preclinical models for nausea and vomiting assessment.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2016; 82():45-53. PubMed ID: 27477617
[TBL] [Abstract][Full Text] [Related]
7. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Lin G; Rudd JA
Toxicol Lett; 2010 Feb; 192(3):402-7. PubMed ID: 19931602
[TBL] [Abstract][Full Text] [Related]
8. Action of metyrapone and tetracosactrin to modify cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Kan KK; Ngan MP; Rudd JA; Yeung JH
Eur J Pharmacol; 2003 Apr; 466(1-2):163-8. PubMed ID: 12679153
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-induced emesis in the Ferret: a new animal model.
Florczyk AP; Schurig JE; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
[TBL] [Abstract][Full Text] [Related]
10. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis.
Rudd JA; Jordan CC; Naylor RJ
Eur J Pharmacol; 1994 Sep; 262(1-2):R1-2. PubMed ID: 7813558
[TBL] [Abstract][Full Text] [Related]
11. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
[TBL] [Abstract][Full Text] [Related]
13. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret.
Rudd JA; Jordan CC; Naylor RJ
Br J Pharmacol; 1996 Nov; 119(5):931-6. PubMed ID: 8922742
[TBL] [Abstract][Full Text] [Related]
14. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA
Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380
[TBL] [Abstract][Full Text] [Related]
15. Emesis induced by cisplatin in the ferret as a model for the detection of anti-emetic drugs.
Costall B; Domeney AM; Naylor RJ; Tattersall FD
Neuropharmacology; 1987 Sep; 26(9):1321-6. PubMed ID: 2890117
[TBL] [Abstract][Full Text] [Related]
16. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets.
Yamakuni H; Sawai-Nakayama H; Imazumi K; Maeda Y; Matsuo M; Manda T; Mutoh S
Eur J Pharmacol; 2002 May; 442(3):273-8. PubMed ID: 12065081
[TBL] [Abstract][Full Text] [Related]
17. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
[TBL] [Abstract][Full Text] [Related]
18. Ondansetron: prevention of nausea & vomiting in cisplatin based chemotherapy.
Cheirsilpa A; Ratanatharathorn V; Sinlarat P; Chindavijak K; Lousoontornsiri W; Chakrapee-Sirisuk S; Srimuninimit V
J Med Assoc Thai; 1994 Apr; 77(4):201-6. PubMed ID: 7844494
[TBL] [Abstract][Full Text] [Related]
19. Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret.
Sam TS; Chan SW; Rudd JA; Yeung JH
Eur J Pharmacol; 2001 Apr; 417(3):231-7. PubMed ID: 11334855
[TBL] [Abstract][Full Text] [Related]
20. The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets.
Marr HE; Davey PT; Boyle EA; Blower PR
J Cancer Res Clin Oncol; 1994; 120(4):204-7. PubMed ID: 8288674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
